ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
China Pharma Holdings Inc

China Pharma Holdings Inc (CPHI)

0.2515
-0.0053
( -2.06% )
Updated: 12:15:05

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.2515
Bid
-
Ask
-
Volume
13,552
0.2512 Day's Range 0.266
0.235 52 Week Range 1.885
Market Cap
Previous Close
0.2568
Open
0.255
Last Trade
100
@
0.2515
Last Trade Time
12:15:05
Financial Volume
$ 3,435
VWAP
0.253481
Average Volume (3m)
341,450
Shares Outstanding
15,870,070
Dividend Yield
-
PE Ratio
-1.29
Earnings Per Share (EPS)
-0.19
Revenue
7.03M
Net Profit
-3.08M

About China Pharma Holdings Inc

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic ... China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
1970
China Pharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker CPHI. The last closing price for China Pharma was $0.26. Over the last year, China Pharma shares have traded in a share price range of $ 0.235 to $ 1.885.

China Pharma currently has 15,870,070 shares outstanding. The market capitalization of China Pharma is $4.08 million. China Pharma has a price to earnings ratio (PE ratio) of -1.29.

CPHI Latest News

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split PR Newswire HAIKOU, China, Feb. 23, 2024 HAIKOU, China, Feb. 23, 2024 /PRNewswire/ -- ChinaΒ Pharma Holdings Inc. ("China Pharma...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0134-5.058512646280.26490.270.24251360130.25629445CS
40.00030.1194267515920.25120.27320.24161061800.26092315CS
12-0.0445-15.03378378380.2960.410.2353414500.30821375CS
26-0.2285-47.60416666670.480.5990.2358584450.41492287CS
52-1.4035-84.80362537761.6551.8850.23516054220.64196278CS
156-34.2485-99.271014492834.548.50.23510341967.04252025CS
260-14.2985-98.271477663214.5581.50.235121039620.91857231CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POAIPredictive Oncology Inc
$ 1.87
(74.77%)
146.51M
SLRXSalarius Pharmaceuticals Inc
$ 3.453
(61.36%)
23.62M
PBMPsyence Biomedical Ltd
$ 0.5841
(49.23%)
72.63M
MIRAMIRA Pharmaceuticals Inc
$ 3.351
(41.99%)
39.25M
VKTXViking Therapeutics Inc
$ 67.905
(34.71%)
12.76M
TWOU2U Inc
$ 1.5901
(-61.41%)
4.11M
KDLYKindly MD Inc
$ 1.99
(-38.20%)
614.63k
CTNTCheetah Net Supply Chain Service Inc
$ 0.30
(-37.76%)
7.6M
EZFLEzFill Holdings Inc
$ 3.9799
(-36.07%)
118.12k
MXLMaxLinear Inc
$ 15.37
(-31.05%)
3.2M
NVDANVIDIA Corporation
$ 114.955
(0.62%)
274.9M
SQQQProShares UltraPro Short QQQ
$ 8.95
(-1.21%)
153.08M
SLNASelina Hospitality PLC
$ 0.04
(-12.47%)
137.91M
POAIPredictive Oncology Inc
$ 1.87
(74.77%)
134.99M
PBMPsyence Biomedical Ltd
$ 0.5841
(49.23%)
67.12M

CPHI Discussion

View Posts
stock1ace1 stock1ace1 2 months ago
15 million you mean?
πŸ‘οΈ0
maestro_of_Ihub maestro_of_Ihub 2 months ago
Wow talk about nightmare earnings! Share outstanding went from 1 million to 13 million! Company in serious risk of filing bankruptcy at this point! Nothing on DED or anything else positive! Wish I never saw this garbage!
πŸ‘οΈ0
Topgun21 Topgun21 3 months ago
Trend is your friend!! $CPHI
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
.35s after hours
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
.31s filling loading before news drops GL if your playing & holding :D
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
.34s p/m
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
1 month left of 1st half 2024 news could drop anyday on 1 million float insiders own 86%

Quote from 2023 news β€”>

Ms. Li Zhilin, CEO of China Pharma said: " After passing third-party testing, this product has obtained qualifications to apply for market approval from NMPA. We are actively working to try to launch this product in the first half of next year.




2023 news below

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

Source: PR Newswire (US)
HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its Dry Eye Disease (DED) therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration (NMPA) of China.

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 344 million patients are suffering from DED worldwide, accounting for 30% of the total number of ophthalmic outpatient visits, with an annual increase of 10%. There are about 80 million DED patients in China, ranking second in ophthalmic diseases.

This device has a utility model patent;
Epidemiological research shows that the incidence rate of DED for all the people in China is about 25% to 30%, and about 75% for people over 65-year-old;
In the field of DED and visual fatigue, this product is expected to fill in the market gap of medical therapeutic apparatus; and
The Company has established sales channels in more than 30 provincial and municipal hospitals, as well as OTC markets in China for more than 20 years. This sales network may strongly support the launch and promotion of this device.
Ms. Li Zhilin, CEO of China Pharma said: " After passing third-party testing, this product has obtained qualifications to apply for market approval from NMPA. We are actively working to try to launch this product in the first half of next year. We are confident that with the patented technological advantages and our sales channels, the launch of this product will bring excellent treatment experience to every DED patient, which will create value for our shareholders."

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.

Safe Harbor Statement

Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties may include, but are not limited to: the achievability of financial guidance; success of new product development; unanticipated changes in product demand; increased competition; downturns in the Chinese economy; uncompetitive levels of research and development; and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations, except as required by applicable law or regulation.

Cision View original content:https://www.prnewswire.com/news-releases/china-pharma-holdings-inc-announced-the-completion-of--third-party-testing-of-dry-eye-disease-therapeutic-device-302000153.html

SOURCE China Pharma Holdings, Inc.


Copyright 2023 PR Newswire
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
.32 chart -> https://schrts.co/NCwWJCPg
πŸ‘οΈ0
stock1ace1 stock1ace1 3 months ago
Watch for news to drop 1 mill float now after r/s in march

QUOTE
β€œβ€We are actively working to try to launch this product in the first half of next year. We are confident that with the patented technological advantages and our sales channels, the launch of this product will bring excellent treatment experience to every DED patient, which will create value for our shareholders."”


after split 1-for 5 (3/6/24)
1 Million float
10 Mill o/s
Insiders own 86% per finviz*

Chart -> https://schrts.co/EjjTrTmK
Finviz -> https://finviz.com/quote.ashx?t=CPHI&p=d






News β€”> 11/29/23

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

Source: PR Newswire (US)
HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its Dry Eye Disease (DED) therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration (NMPA) of China.

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 344 million patients are suffering from DED worldwide, accounting for 30% of the total number of ophthalmic outpatient visits, with an annual increase of 10%. There are about 80 million DED patients in China, ranking second in ophthalmic diseases.

This device has a utility model patent;
Epidemiological research shows that the incidence rate of DED for all the people in China is about 25% to 30%, and about 75% for people over 65-year-old;
In the field of DED and visual fatigue, this product is expected to fill in the market gap of medical therapeutic apparatus; and
The Company has established sales channels in more than 30 provincial and municipal hospitals, as well as OTC markets in China for more than 20 years. This sales network may strongly support the launch and promotion of this device.
Ms. Li Zhilin, CEO of China Pharma said: " After passing third-party testing, this product has obtained qualifications to apply for market approval from NMPA. We are actively working to try to launch this product in the first half of next year. We are confident that with the patented technological advantages and our sales channels, the launch of this product will bring excellent treatment experience to every DED patient, which will create value for our shareholders."

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.

Safe Harbor Statement

Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties may include, but are not limited to: the achievability of financial guidance; success of new product development; unanticipated changes in product demand; increased competition; downturns in the Chinese economy; uncompetitive levels of research and development; and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations, except as required by applicable law or regulation.

Cision View original content:https://www.prnewswire.com/news-releases/china-pharma-holdings-inc-announced-the-completion-of--third-party-testing-of-dry-eye-disease-therapeutic-device-302000153.html

SOURCE China Pharma Holdings, Inc.


Copyright 2023 PR Newswire
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
CPHI new 52 lo
πŸ‘οΈ0
PennyPusher786 PennyPusher786 5 months ago
No I mean days later when you look at the chart, and I'm using it on the mobile app... perhaps it's a different set up online.

But ihub on the mobile app doesn't show you the high of the day on the chart when you look back up to 3 years. It shows the Closing price.

Like I said, perhaps it's different on the desktop app
πŸ‘οΈ0
lucky, mydog lucky, mydog 5 months ago
ihub doesn't show the high of day

sure it does.

https://ih.advfn.com/stock-market/AMEX/china-pharma-CPHI/stock-price
πŸ‘οΈ0
Renee Renee 5 months ago
CPHI: effective March 6,2024 a one for 5 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
πŸ‘οΈ0
81vette 81vette 5 months ago
So far so good,no r/s today at least(usually immediately after close,4pm)
πŸ‘οΈ0
81vette 81vette 5 months ago
https://www.bing.com/search?q=why+do+companies+file+an+S-3+notice+of+effectiveness&qs=n&form=QBRE&sp=-1&lq=0&pq=why+do+companies+file+an+s-3+notice+of+effectiveness&sc=6-52&sk=&cvid=EC657C8D81EE4DA088E54A28A79C767C&ghsh=0&ghacc=0&ghpl=
πŸ‘οΈ0
81vette 81vette 5 months ago
just noticed it trades on amex exchange,thats the otc of big boards imo
πŸ‘οΈ0
81vette 81vette 5 months ago
always go with your gut,trusting a china ticker is like trusting a fart,sometimes you get shit on,lol
πŸ‘οΈ0
eyeownu eyeownu 5 months ago
would like to take a position but somethings says WAIT
πŸ‘οΈ0
81vette 81vette 5 months ago
AGBA private placement closed 3 hrs ago,shares ava. to short dropping,charting bullish,looking good!!!
πŸ‘οΈ0
PennyPusher786 PennyPusher786 5 months ago
Personally, I think better odds on the Chinese ticker $AGBA
πŸ‘οΈ0
PennyPusher786 PennyPusher786 5 months ago
Makes sense, I always forget, ihub doesn't show the high of day, just the close... lol silly me...

Good luck... sometimes reverse Splits bank big... depends whose involved
πŸ‘οΈ0
81vette 81vette 5 months ago
1 for10 r/s was approved in dec.can be effected anytime,it could be coming after close today,i wont be holding thru close just in case
👍️ 1
81vette 81vette 5 months ago
it went from lod .11 to hod .23,but yea 100m vol @.15 ave=$15m,i would expect a much bigger move from that much vol,must have been a bunch of debt paid off that day,or dark pool crooked mms,a 1 for 10 r/s was approved in dec. and it says can be effected anytime,could be effective after close,the effect today doesnt say what it is,but i wont be holding thru close today just incase
πŸ‘οΈ0
PennyPusher786 PennyPusher786 5 months ago
In December, they had 100 million volume, but they only moved from .10 - .13 cents... 30% is still an amazing win I guess
πŸ‘οΈ0
81vette 81vette 5 months ago
http://www.chinapharmaholdings.com/
πŸ‘οΈ0
81vette 81vette 5 months ago
maybe urine lol,the last 8k filing was a definitive material agreement for patent purchase of a psoriasis product,maybe its poop lol ,they paid 15m shares and 5m restricted ($2M) and 10% of profit for 10 years
πŸ‘οΈ0
Triple nickle Triple nickle 5 months ago
What’s the dry eye devise a bottle of visine. CPHI
πŸ‘οΈ0
81vette 81vette 5 months ago
https://capedge.com/filing/1106644/9999999995-24-000463/CPHI-EFFECT ,usually comes with 8k detail filing of what effect occurred,this 13g filed yesterday, the last filing was definitive agreement of patent transfer,maybe that has taken effect> https://capedge.com/filing/1106644/0001213900-24-011587/CPHI-8K
πŸ‘οΈ0
81vette 81vette 5 months ago
haven't ran since nov,oversold,poked head above ma's today(hint of bullish start)with china hype lately and .10pps i think its a prime suspect for interest,and if the expected merger news hits it should do well
πŸ‘οΈ0
81vette 81vette 5 months ago
sales 7.78m,book .21,mkt cap 5.57m,float 21m,o/s 57m
πŸ‘οΈ0
81vette 81vette 5 months ago
ran to .2310 on nov 29th with 105m traded
πŸ‘οΈ0
81vette 81vette 5 months ago
shares ava. to short is high 800k,has dropped to zero borrow before with vol.,but who in right mind shorts from a dime
πŸ‘οΈ0
81vette 81vette 5 months ago
china runner starting!!!
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 6 months ago
Rock on Fish on start reeling $$$$$$
πŸ‘οΈ0
maestro_of_Ihub maestro_of_Ihub 6 months ago
So the Taylor Swift of China now owns 15 million shares of this? https://en.wikipedia.org/wiki/Liu_Tao
πŸ‘οΈ0
maestro_of_Ihub maestro_of_Ihub 6 months ago
So the Taylor Swift of China now owns 15 million shares of this? https://en.wikipedia.org/wiki/Liu_Tao
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
CPHI: Got some of this Chinese Un-Fortunate-Cookie @$0.1255 in the Post-M today, for my personal amusement. ("Mark's" mention on the Orions Board, due filings just now; even though he HATES it.)


PS: I got married AGAIN, last Sunday, in a local San Diego Atheists' Chapel! Check-out a clip from the ceremony, above!! She's a veritable DOLL, ain't she??!! We're flyin' to PALESTINE for our honeymoon!! Booked a nice suite in a Motel-6 there, in the Golan Heights, run by a Jewish buddy of mine!!
πŸ‘οΈ0
TheFinalCD TheFinalCD 6 months ago
i WONDER IF THIS IS THE SAME GUY

https://www.propublica.org/article/liu-tao-trump-meeting-china-investigation
https://ih.advfn.com/stock-market/AMEX/china-pharma-CPHI/stock-news/93151163/form-sc-13g-statement-of-acquisition-of-benefici


CPHI January 2024 Shelf
EDGAR
Pending Effect

Current Raisable Amount
$16,532,168
Total Shelf Capacity
$50,000,000


https://dilutiontracker.com/app/search/CPHI?a=dbb88c
πŸ‘οΈ0
Tyrus603 Tyrus603 8 months ago
"Fake news?" Congrats to all you CPHI shareholders on your incoming 33,000 % gains!

CNN financials page analyst says "price target $45. Revenues $37M. EPS $2+."

But the NYSE stock's actually trading at 13 cents and market cap of $4M?

WTAF is true anymore?

https://money.cnn.com/quote/quote.html?symb=CPHI#:~:text=China%20Pharma%20Holdings%20Inc%20(NYSE%20American%3ACPHI)

https://twitter.com/tyrus603/status/1732100139550965843?t=DoOtwX4vmgUKX8MPn5oKtg&s=19
πŸ‘οΈ0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 months ago
$CPHI ~ China Pharma Holdings Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its Dry Eye Disease (DED) therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration (NMPA) of China.

Link: https://finance.yahoo.com/news/china-pharma-holdings-inc-announced-130000348.html

$$$CPHI$$$
πŸ‘οΈ0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 months ago
Form_4 filing shows Li Zhilin as the owner of 15,138,063 $CPHI shares. WOW!

https://www.otcmarkets.com/filing/html?id=16995596&guid=WuJ-kahrG2lS-ch#OWNERSHIP_HTM_F1
πŸ‘οΈ0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 months ago
$CPHI >>> 1Y/Daily Chart~



$$$CPHI$$$
πŸ‘οΈ0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 months ago
$CPHI ~ 180day/daily Chart~



$$$CPHI$$$
πŸ‘οΈ0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 months ago
$CPHI ~ China Pharma Holdings Inc @$.13
+0.0051 (+4.08%)
Volume: 2,905,839
Day Range: 0.125 - 0.142
Last Trade Time: 5:48:57 PM EST




$$$CPHI$$$
πŸ‘οΈ0
webprods webprods 8 months ago
Buyout ?
πŸ‘οΈ0
maestro_of_Ihub maestro_of_Ihub 8 months ago
45 cents works for me!
πŸ‘οΈ0
webprods webprods 8 months ago
Patience will bring $45 per share here.
πŸ‘οΈ0
maestro_of_Ihub maestro_of_Ihub 8 months ago
Buy at the open!
πŸ‘οΈ0
webprods webprods 8 months ago
With that small OS stock price can be 10 cents or 1 dollar or 80 dollars. Nobody know where this stock can go. Only one thing I don’t like. This is a China company and can be like thousands others fraudulent company. Going up 123% and finish at low 13% isn’t a good signal for potential traders or investors. Today we got massive pump and at close profits takers. As I can see from volume just a few people playing this game what is another red flag. However to not be sorry for myself I got a nice bag here in the case that this is true company.
πŸ‘οΈ0
webprods webprods 8 months ago
Yeah. But as you can see looks like pump. Let’s see tomorrow. We’ll have confirmation that is pump or not. Today is normal that peeps taking profit from 120% run.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock